News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News News HIV Vaccines 03/05/2023 IrsiCaixa designs HIV-like particles that induce an effective immune response in preclinical studies HIV 13/04/2023 New insights on the early stages of HIV infection in the human body SARS-CoV-2 Vaccines 31/03/2023 HIPRA's COVID-19 vaccine, developed with the scientific support of IrsiCaixa, receives a positive opinion from the European Medicines Agency HIV PrEP 30/03/2023 More accessible PrEP to promote HIV prevention in Spain SARS-CoV-2 29/03/2023 3 years of COVID-19: from emergency research to a consolidated study area Post COVID-19 20/03/2023 IrsiCaixa receives a grant from Barcelona City Council to study long COVID in children Organoids 07/03/2023 Creation of the first biobank of farm animal organoids in Spain based on a project with the participation of IrsiCaixa SARS-CoV-2 Therapies 01/03/2023 Preventing SARS-CoV-2 infection thanks to a bacterial-derived molecule HIV Therapies 20/02/2023 World's third case of HIV cure after stem cell transplant Pagination First Previous Page 1 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
HIV Vaccines 03/05/2023 IrsiCaixa designs HIV-like particles that induce an effective immune response in preclinical studies
SARS-CoV-2 Vaccines 31/03/2023 HIPRA's COVID-19 vaccine, developed with the scientific support of IrsiCaixa, receives a positive opinion from the European Medicines Agency
Post COVID-19 20/03/2023 IrsiCaixa receives a grant from Barcelona City Council to study long COVID in children
Organoids 07/03/2023 Creation of the first biobank of farm animal organoids in Spain based on a project with the participation of IrsiCaixa
SARS-CoV-2 Therapies 01/03/2023 Preventing SARS-CoV-2 infection thanks to a bacterial-derived molecule
